Case number 1:20-cv-00650
UCB Pharma S.A. et al v. Nektar Therapeutics > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Oct 19, 2021 | 81 | Stipulation of Dismissal (2) Docket Text: STIPULATION of Dismissal by Celltech R&D Limited, UCB Pharma S.A.. (Egan, Brian) |
| Oct 19, 2021 | 82 | Stipulation and Order (2) Docket Text: STIPULATION AND ORDER (Case Closed). Signed by Judge Colm F. Connolly on 10/19/2021. (kmd) |
| Oct 19, 2021 | 83 | Patent/Trademark Report to Commissioner (Main Document) (1) Docket Text: Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 7,767,784 B2; 8,193,306 B2; 8,461,295 B2; 8,809,489 B2. (Attachments: # (1) Stipulation and Order of Dismissal)(kmd) |
| Oct 19, 2021 | 83 | Patent/Trademark Report to Commissioner (Stipulation and Order of Dismissal) (2) Docket Text: Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 7,767,784 B2; 8,193,306 B2; 8,461,295 B2; 8,809,489 B2. (Attachments: # (1) Stipulation and Order of Dismissal)(kmd) |
| Jun 30, 2021 | 80 | Order Staying Case (2) Docket Text: ORDER STAYING CASE pending resolution of the Arbitration; IT IS FURTHER ORDERED that the claim construction entered by the Court during the June 17, 2021 Markman hearing is binding upon the Parties in the Arbitration. Signed by Judge Colm F. Connolly on 6/30/2021. (nmf) |
| Jun 25, 2021 | 79 | Status Report (Main Document) (2) Docket Text: Joint STATUS REPORT by Celltech R&D Limited, UCB Pharma S.A.. (Attachments: # (1) Text of Proposed Order)(Raucci, Anthony) |
| Jun 25, 2021 | 79 | Status Report (Text of Proposed Order) (2) Docket Text: Joint STATUS REPORT by Celltech R&D Limited, UCB Pharma S.A.. (Attachments: # (1) Text of Proposed Order)(Raucci, Anthony) |
| Jun 17, 2021 | N/A | Markman Hearing (0) Docket Text: Minute Entry for proceedings held before Judge Colm F. Connolly - Markman Hearing held on 6/17/2021, Oral Argument held on 6/17/2021. (Court Reporter V. Gunning.) (nmf) |
| Jun 17, 2021 | N/A | Oral Order (0) Docket Text: ORAL ORDER: IT IS HEREBY ORDERED that, for the reasons articulated by the Court at today's claim construction hearing, the claim term "substantially all of the unreacted di(1-benzotriazolyl) carbonate" is construed to mean "(unless specifically defined for a particular context elsewhere or the context clearly dictates otherwise) nearly totally or completely, for instance, satisfying one or more of the following: greater than 50%, 51% or greater, 75% or greater, 80% or greater, 90% or greater, and 95% or greater of the unreacted di(1- benzotriazolyl) carbonate." Ordered by Judge Colm F. Connolly on 6/17/2021. (nmf) |
| Jun 17, 2021 | N/A | Oral Order (0) Docket Text: ORAL ORDER: It is hereby ORDERED that the case is STAYED pending the Court's determination of whether a stay should be imposed pending the resolution of the parties' arbitration proceedings. It is further ORDERED that the parties shall meet and confer and submit a joint status report no later than June 25, 2021. Case stayed. Ordered by Judge Colm F. Connolly on 6/17/2021. (nmf) |
| Jun 15, 2021 | 78 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of (1) UCB Pharma S.A. and Celltech R&D Limited's Second Set of Requests for Production of Documents, ESI, and Things (Nos. 46-58) and (2) Plaintiffs' Third Set of Interrogatories (Nos. 10-15) filed by Celltech R&D Limited, UCB Pharma S.A..(Raucci, Anthony) |
| Jun 11, 2021 | 77 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Defendants Response to Plaintiffs Supplemental Invalidity Contentions filed by Nektar Therapeutics.(Farnan, Kelly) |
| Jun 7, 2021 | N/A | Oral Order (0) Docket Text: ORAL ORDER: The Court will hear oral argument on Defendant's motion to enjoin arbitration (D.I. [30]) immediately after the Court orally issues its claim construction ruling on June 17, 2021. Ordered by Judge Colm F. Connolly on 6/7/2021. (nmf) |
| Jun 3, 2021 | 76 | Letter (2) Docket Text: Letter to The Honorable Colm F. Connolly from Anthony D. Raucci regarding Claim Construction Meet and Confer. (Raucci, Anthony) |
| Jun 1, 2021 | 74 | Redacted Document (30) Docket Text: REDACTED VERSION of [71] Joint Claim Construction Brief by Celltech R&D Limited, UCB Pharma S.A.. (Raucci, Anthony) |
| Jun 1, 2021 | 75 | Redacted Document (30) Docket Text: REDACTED VERSION of [72] Appendix by Celltech R&D Limited, UCB Pharma S.A.. (Raucci, Anthony) |
| May 26, 2021 | 73 | Letter (1) Docket Text: Letter to The Honorable Colm F. Connolly from Anthony D. Raucci regarding request to combine oral argument on Motion to Enjoin with Markman hearing. (Raucci, Anthony) |
| May 21, 2021 | 70 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of Plaintiffs' Supplemental Invalidity Contentions filed by Celltech R&D Limited, UCB Pharma S.A..(Raucci, Anthony) |
| May 17, 2021 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, [68] Stipulation to Set Deadlines for Supplementation of Invalidity Contentions and Responses. ORDERED by Judge Jennifer L. Hall on 5/17/2021. (ceg) |
| May 14, 2021 | 68 | Stipulation (2) Docket Text: STIPULATION to Set Deadlines for Supplementation of Invalidity Contentions and Responses Thereto by Celltech R&D Limited, UCB Pharma S.A.. (Raucci, Anthony) |
| May 14, 2021 | 69 | Notice (Other) (2) Docket Text: NOTICE of Service of Defendant's Sur-Reply Claim Construction Brief by Nektar Therapeutics (Farnan, Kelly) |
| May 12, 2021 | 67 | Claim Construction Chart (6) Docket Text: CLAIM Construction Chart by Celltech R&D Limited, UCB Pharma S.A.. (Raucci, Anthony) |
| May 10, 2021 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [65] STIPULATION TO EXTEND TIME to substantially complete document production to through and including June 1, 2021 filed by Nektar Therapeutics. Signed by Judge Colm F. Connolly on 5/10/2021. (fms) |
| May 7, 2021 | 65 | Stipulation to EXTEND Time (2) Docket Text: STIPULATION TO EXTEND TIME to substantially complete document production to through and including June 1, 2021 - filed by Nektar Therapeutics. (Farnan, Kelly) |
| May 7, 2021 | 66 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of Plaintiffs' Reply Claim Construction Brief filed by Celltech R&D Limited, UCB Pharma S.A..(Raucci, Anthony) |
| May 3, 2021 | 64 | Memorandum and Order (2) Docket Text: MEMORANDUM ORDER OVERRULING [62] Objections filed by Nektar Therapeutics. Signed by Judge Colm F. Connolly on 5/3/2021. (nmf) |
| Apr 28, 2021 | 63 | Letter (1) Docket Text: Letter to The Honorable Colm F. Connolly from Kelly E. Farnan regarding enclosing courtesy copies of document relating to objections - re [48] Letter, [54] Letter, [55] Letter, [50] Letter. (Farnan, Kelly) |
| Apr 26, 2021 | 61 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Defendant's Answering Claim Construction Brief filed by Nektar Therapeutics.(Farnan, Kelly) |
| Apr 26, 2021 | 62 | Objections (Main Document) (16) Docket Text: OBJECTIONS by Nektar Therapeutics to [58] Oral Order . (Attachments: # (1) Exhibit A-B)(Farnan, Kelly) |
| Apr 26, 2021 | 62 | Objections (Exhibit A-B) (30) Docket Text: OBJECTIONS by Nektar Therapeutics to [58] Oral Order . (Attachments: # (1) Exhibit A-B)(Farnan, Kelly) |
| Apr 14, 2021 | 60 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of Plaintiffs Responses and Objections to Defendants First Set of Interrogatories (Nos. 1-12) filed by Celltech R&D Limited, UCB Pharma S.A..(Raucci, Anthony) |
| Apr 12, 2021 | N/A | Discovery Conference (0) Docket Text: Minute Entry for proceedings held before Judge Jennifer L. Hall - Discovery Dispute Teleconference held on 4/12/2021. (*Court Reporter Stacy Ingram) (ceg) |
| Apr 12, 2021 | N/A | Oral Order (0) Docket Text: ORAL ORDER: IT IS HEREBY ORDERED that the transcript of the April 12, 2021 discovery dispute teleconference shall serve as the Order of the Court. ORDERED by Judge Jennifer L. Hall on 4/12/2021. (ceg) |
| Apr 12, 2021 | 59 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Defendant's Responses and Objections to Plaintiffs' Second Set of Interrogatories (Nos. 8-9) filed by Nektar Therapeutics.(Farnan, Kelly) |
| Apr 9, 2021 | 57 | Notice of Service (4) Docket Text: NOTICE OF SERVICE of Plaintiffs' Opening Claim Construction Brief filed by Celltech R&D Limited, UCB Pharma S.A..(Raucci, Anthony) |
| Apr 5, 2021 | 53 | Redacted Document (16) Docket Text: REDACTED VERSION of [47] Reply Brief by Nektar Therapeutics. (Farnan, Kelly) |
| Apr 5, 2021 | 54 | Letter (Main Document) (4) Docket Text: Letter to The Honorable Jennifer L. Hall from Anthony D. Raucci regarding responsive letter re discovery dispute - re [48] Letter,. (Attachments: # (1) Exhibit 5)(Raucci, Anthony) |
| Apr 5, 2021 | 54 | Letter (Exhibit 5) (1) Docket Text: Letter to The Honorable Jennifer L. Hall from Anthony D. Raucci regarding responsive letter re discovery dispute - re [48] Letter,. (Attachments: # (1) Exhibit 5)(Raucci, Anthony) |
| Apr 5, 2021 | 55 | Letter (Main Document) (3) Docket Text: Letter to Honorable Jennifer L. Hall from Kelly E. Farnan regarding submission of responsive letter brief in opposition to Motion to Compel. (Attachments: # (1) Exhibit A)(Farnan, Kelly) |
| Apr 5, 2021 | 55 | Letter (Exhibit A) (6) Docket Text: Letter to Honorable Jennifer L. Hall from Kelly E. Farnan regarding submission of responsive letter brief in opposition to Motion to Compel. (Attachments: # (1) Exhibit A)(Farnan, Kelly) |
| Apr 5, 2021 | 56 | Redacted Document (Main Document) (4) Docket Text: REDACTED VERSION of [50] Letter by Celltech R&D Limited, UCB Pharma S.A.. (Attachments: # (1) Text of Proposed Order, # (2) Exhibits 1-4)(Raucci, Anthony) |
| Apr 5, 2021 | 56 | Redacted Document (Text of Proposed Order) (1) Docket Text: REDACTED VERSION of [50] Letter by Celltech R&D Limited, UCB Pharma S.A.. (Attachments: # (1) Text of Proposed Order, # (2) Exhibits 1-4)(Raucci, Anthony) |
| Apr 5, 2021 | 56 | Redacted Document (Exhibits 1-4) (30) Docket Text: REDACTED VERSION of [50] Letter by Celltech R&D Limited, UCB Pharma S.A.. (Attachments: # (1) Text of Proposed Order, # (2) Exhibits 1-4)(Raucci, Anthony) |
| Apr 1, 2021 | 52 | Request for Oral Argument (2) Docket Text: REQUEST for Oral Argument by Celltech R&D Limited, UCB Pharma S.A. re [30] MOTION to Enjoin Arbitration. (Raucci, Anthony) |
| Mar 29, 2021 | N/A | Motions No Longer Referred (0) Docket Text: Motions No Longer Referred: [49] MOTION for Claim Construction re [46] Claim Construction Chart , [51] MOTION for Claim Construction (fms) |
| Mar 29, 2021 | N/A | CORRECTING ENTRY: (0) Docket Text: CORRECTING ENTRY: The docket text and attachment labels on D.I. [46] have been corrected to comply with Judge Connolly's requirement that each separate pdf shall be labeled using the last three digits of the number of the patent in question so that it is possible to determine from looking at the docket sheet the patent in a particular exhibit. (fms) |
| Mar 26, 2021 | 45 | Redacted Document (Main Document) (24) Docket Text: REDACTED VERSION of [44] Answering Brief in Opposition, by Celltech R&D Limited, UCB Pharma S.A.. (Attachments: # (1) Exhibit A & B)(Raucci, Anthony) |
| Mar 26, 2021 | 45 | Redacted Document (Exhibit A & B) (4) Docket Text: REDACTED VERSION of [44] Answering Brief in Opposition, by Celltech R&D Limited, UCB Pharma S.A.. (Attachments: # (1) Exhibit A & B)(Raucci, Anthony) |
| Mar 26, 2021 | 46 | Claim Construction Chart (Main Document) (8) Docket Text: CLAIM Construction Chart by Celltech R&D Limited, UCB Pharma S.A.. (Attachments: # (1) Exhibit A - '784 # (2) Exhibit B - '306 # (3) Exhibit C -'295 # (4) Exhibit D - '489)(Raucci, Anthony) Modified on 3/29/2021 (fms). |
| Mar 26, 2021 | 46 | Claim Construction Chart (Exhibit A - '784) (19) Docket Text: CLAIM Construction Chart by Celltech R&D Limited, UCB Pharma S.A.. (Attachments: # (1) Exhibit A - '784 # (2) Exhibit B - '306 # (3) Exhibit C -'295 # (4) Exhibit D - '489)(Raucci, Anthony) Modified on 3/29/2021 (fms). |
| Mar 26, 2021 | 46 | Claim Construction Chart (Exhibit B - '306) (22) Docket Text: CLAIM Construction Chart by Celltech R&D Limited, UCB Pharma S.A.. (Attachments: # (1) Exhibit A - '784 # (2) Exhibit B - '306 # (3) Exhibit C -'295 # (4) Exhibit D - '489)(Raucci, Anthony) Modified on 3/29/2021 (fms). |
| Mar 26, 2021 | 46 | Claim Construction Chart (Exhibit C - '295) (21) Docket Text: CLAIM Construction Chart by Celltech R&D Limited, UCB Pharma S.A.. (Attachments: # (1) Exhibit A - '784 # (2) Exhibit B - '306 # (3) Exhibit C -'295 # (4) Exhibit D - '489)(Raucci, Anthony) Modified on 3/29/2021 (fms). |
| Mar 26, 2021 | 46 | Claim Construction Chart (Exhibit D - '489) (21) Docket Text: CLAIM Construction Chart by Celltech R&D Limited, UCB Pharma S.A.. (Attachments: # (1) Exhibit A - '784 # (2) Exhibit B - '306 # (3) Exhibit C -'295 # (4) Exhibit D - '489)(Raucci, Anthony) Modified on 3/29/2021 (fms). |
| Mar 26, 2021 | 48 | Letter (Main Document) (3) Docket Text: Letter to The Honorable Jennifer L. Hall from Kelly E. Farnan regarding Response to Court's March 19, 2021 Order - re [43] Order Setting Teleconference,,,,. (Attachments: # (1) Exhibit A-B)(Farnan, Kelly) (Additional attachment(s) added on 3/29/2021: # (2) Text of Proposed Order) (ceg). |
| Mar 26, 2021 | 48 | Letter (Exhibit A-B) (30) Docket Text: Letter to The Honorable Jennifer L. Hall from Kelly E. Farnan regarding Response to Court's March 19, 2021 Order - re [43] Order Setting Teleconference,,,,. (Attachments: # (1) Exhibit A-B)(Farnan, Kelly) (Additional attachment(s) added on 3/29/2021: # (2) Text of Proposed Order) (ceg). |
| Mar 26, 2021 | 48 | Letter (Text of Proposed Order) (1) Docket Text: Letter to The Honorable Jennifer L. Hall from Kelly E. Farnan regarding Response to Court's March 19, 2021 Order - re [43] Order Setting Teleconference,,,,. (Attachments: # (1) Exhibit A-B)(Farnan, Kelly) (Additional attachment(s) added on 3/29/2021: # (2) Text of Proposed Order) (ceg). |
| Mar 26, 2021 | 49 | Motion for Miscellaneous Relief (4) Docket Text: MOTION for Claim Construction re [46] Claim Construction Chart - filed by Celltech R&D Limited, UCB Pharma S.A. (Raucci, Anthony) Modified on 3/29/2021 (fms). |
| Mar 26, 2021 | 51 | Motion for Miscellaneous Relief (2) Docket Text: MOTION for Claim Construction - filed by Nektar Therapeutics. (Farnan, Kelly) Modified on 3/29/2021 (fms). |
| Mar 19, 2021 | N/A | Order Setting Teleconference (0) Docket Text: ORAL ORDER Setting Teleconference: The Court has reviewed the Joint Motion for Teleconference to Resolve Discovery Dispute (D.I. [42]). A discovery dispute teleconference is scheduled for April 12, 2021 at 2:00 PM Eastern Time before Judge Jennifer L. Hall. By no later than March 26, 2021 the party(ies) seeking relief shall file with the Court a letter, not to exceed three pages, in no less than 12-point font, outlining the issues in dispute and its position on those issues. By no later than April 5, 2021 any party(ies) opposing the application for relief may file a letter, not to exceed three pages, in no less than 12-point font, outlining that party's reasons for its opposition. Counsel is reminded to provide courtesy copies. Counsel shall send dial-in information directly to the Court, no later than 24 hours prior to the hearing, using the following e-mail address: Cailah_Garfinkel@ded.uscourts.gov. The Court may choose to resolve the dispute prior to the telephone conference and will, in that event, cancel the conference. ORDERED by Judge Jennifer L. Hall on 3/19/2021. (ceg) |
| Mar 18, 2021 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney James S. Trainor, Jr, Robert E. Counihan, and Kathryn Easterling for UCB Pharma S.A. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (sam) |
| Mar 18, 2021 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney Melanie M. Mayer, and Catherine H. McCord for UCB Pharma S.A. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (sam) |
| Mar 18, 2021 | 41 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of Plaintiffs Responses and Objections to Defendants First Set of Requests to Plaintiffs for the Production of Documents and Things (Nos. 1-28) filed by Celltech R&D Limited, UCB Pharma S.A..(Raucci, Anthony) |
| Mar 18, 2021 | 42 | Motion for Miscellaneous Relief (2) Docket Text: Joint MOTION for Teleconference to Resolve Discovery Dispute - filed by Nektar Therapeutics. Motions referred to Jennifer L. Hall.(Farnan, Kelly) |
| Mar 17, 2021 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [38] MOTION for Pro Hac Vice Appearance of Attorney Melanie L. Mayer and Catherine McCord filed by UCB Pharma S.A., Celltech R&D Limited. Signed by Judge Colm F. Connolly on 3/17/2021. (fms) |
| Mar 17, 2021 | 38 | Motion for Leave to Appear Pro Hac Vice (5) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Melanie L. Mayer and Catherine McCord - filed by Celltech R&D Limited, UCB Pharma S.A.. (Raucci, Anthony) |
| Mar 17, 2021 | 39 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of Plaintiffs UCB Pharma S.A.s and Celltech R&D Limiteds Citations to Rebuttal Claim Construction filed by Celltech R&D Limited, UCB Pharma S.A..(Raucci, Anthony) |
| Mar 17, 2021 | 40 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Defendant Nektar Therapeutics' Response to Plaintiffs' Identification of Proposed Claim Constructions and Intrinsic Evidence filed by Nektar Therapeutics.(Farnan, Kelly) |
| Mar 15, 2021 | N/A | Oral Order (0) Docket Text: ORAL ORDER REFERRING CASE to Magistrate Judge Jennifer L. Hall for all disputes related to discovery or the protective order. Ordered by Judge Colm F. Connolly on 3/15/2021. (nmf) |
| Mar 15, 2021 | 36 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Defendants First Set of Interrogatories to Plaintiffs (Nos. 1-12) filed by Nektar Therapeutics.(Farnan, Kelly) |
| Mar 15, 2021 | N/A | Oral Order (0) Docket Text: ORAL ORDER: A Motion for Teleconference to Resolve Discovery Dispute should be filed if counsel finds they are unable to resolve a discovery matter. The suggested text for this motion can be found in Judge Hall's portion of the Court's website, in the "Forms" tab, under the heading "Motion for Teleconference to Resolve Discovery/Protective Order Disputes." The dispute will thereafter be addressed in accordance with Judge Hall's discovery dispute procedures. ORDERED by Judge Jennifer L. Hall on 3/15/2021. (ceg) |
| Mar 12, 2021 | 34 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of Plaintiffs' Second Set of Interrogatories to Defendant (Nos. 8-9) - filed by Celltech R&D Limited, UCB Pharma S.A..(Raucci, Anthony) |
| Mar 12, 2021 | 35 | Redacted Document (Main Document) (22) Docket Text: REDACTED VERSION of [31] Opening Brief in Support, by Nektar Therapeutics. (Attachments: # (1) Exhibit 1-2)(Farnan, Kelly) |
| Mar 12, 2021 | 35 | Redacted Document (Exhibit 1-2) (8) Docket Text: REDACTED VERSION of [31] Opening Brief in Support, by Nektar Therapeutics. (Attachments: # (1) Exhibit 1-2)(Farnan, Kelly) |
| Mar 8, 2021 | N/A | CORRECTING ENTRY: (0) Docket Text: CORRECTING ENTRY: The Sealed Opening Brief at D.I. [31] has been removed and replaced with a revised version per request of filer. (fms) |
| Mar 8, 2021 | 33 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Compendium of Authorities in Support of Defendants Motion to Enjoin Arbitration (D.I. 30) re [30] MOTION to Enjoin Arbitration filed by Nektar Therapeutics.(Farnan, Kelly) |
| Mar 5, 2021 | 30 | Motion to Enjoin (Main Document) (2) Docket Text: MOTION to Enjoin Arbitration - filed by Nektar Therapeutics. (Attachments: # (1) 7.1.1 Certification, # (2) Text of Proposed Order Proposed Order)(Farnan, Kelly) |
| Mar 5, 2021 | 30 | Motion to Enjoin (7.1.1 Certification) (2) Docket Text: MOTION to Enjoin Arbitration - filed by Nektar Therapeutics. (Attachments: # (1) 7.1.1 Certification, # (2) Text of Proposed Order Proposed Order)(Farnan, Kelly) |
| Mar 5, 2021 | 30 | Motion to Enjoin (Text of Proposed Order Proposed Order) (1) Docket Text: MOTION to Enjoin Arbitration - filed by Nektar Therapeutics. (Attachments: # (1) 7.1.1 Certification, # (2) Text of Proposed Order Proposed Order)(Farnan, Kelly) |
| Mar 5, 2021 | 32 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of Plaintiffs UCB Pharma S.A.s and Celltech R&D Limiteds Identification of Proposed Claim Constructions and Intrinsic Evidence filed by Celltech R&D Limited, UCB Pharma S.A..(Raucci, Anthony) |
| Feb 26, 2021 | 29 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of Plaintiffs UCB Pharma S.A.'s and Celltech R&D Limited's Identification of Claim Terms/Phrases for Construction - filed by Celltech R&D Limited, UCB Pharma S.A..(Egan, Brian) |
| Feb 16, 2021 | 28 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Defendants First Set of Requests to Plaintiffs for the Production of Documents and Things (Nos. 1-28) filed by Nektar Therapeutics.(Farnan, Kelly) |
| Feb 11, 2021 | 27 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of (1) Responses and Objections to Plaintiffs' First Set of Interrogatories (Nos. 1-7) and (2) Responses and Objections to UCB Pharma S.A.'s and Celltech R&D Limited's First Set of Requests for Production of Documents, ESI, and Things (Nos. 1-45) filed by Nektar Therapeutics.(Caras, Valerie) |
| Jan 19, 2021 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [25] Proposed Order filed by UCB Pharma S.A., Celltech R&D Limited, [26] Proposed Order filed by UCB Pharma S.A., Celltech R&D Limited. Ordered by Judge Colm F. Connolly on 1/19/2021. (fms) |
| Jan 15, 2021 | 25 | Proposed Order (10) Docket Text: PROPOSED ORDER Stipulated Order Regarding the Discovery of Electronically Stored Information by Celltech R&D Limited, UCB Pharma S.A.. (Raucci, Anthony) |
| Jan 15, 2021 | 26 | Proposed Order (30) Docket Text: PROPOSED ORDER Stipulated Protective Order by Celltech R&D Limited, UCB Pharma S.A.. (Raucci, Anthony) |
| Jan 11, 2021 | 24 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Defendant Nektar Therapeutics Disclosures Pursuant to Paragraph 3 of the District of Delaware Default Standard for Discovery filed by Nektar Therapeutics.(Farnan, Kelly) |
| Jan 5, 2021 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [22] Joint STIPULATION TO EXTEND TIME for the parties to submit a Proposed ESI Order and Proposed Protective Order to January 15, 2021 filed by UCB Pharma S.A., Celltech R&D Limited. Signed by Judge Colm F. Connolly on 1/5/2021. (fms) |
| Jan 5, 2021 | 22 | Stipulation to EXTEND Time (2) Docket Text: Joint STIPULATION TO EXTEND TIME for the parties to submit a Proposed ESI Order and Proposed Protective Order to January 15, 2021 - filed by Celltech R&D Limited, UCB Pharma S.A.. (Raucci, Anthony) |
| Jan 5, 2021 | 23 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of (1) Plaintiffs First Set of Interrogatories (Nos. 1-7) ; and (2) UCB Pharma S.A.s and Celltech R & D Limiteds First Set of Requests for Production of Documents, ESI and Things (Nos. 1-45) filed by Celltech R&D Limited, UCB Pharma S.A..(Raucci, Anthony) |
| Dec 23, 2020 | 20 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Defendant Nektar Therapeutics Rule 26(a)(1) Initial Disclosures filed by Nektar Therapeutics.(Farnan, Kelly) |
| Dec 23, 2020 | 21 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of (1) Plaintiffs Initial Invalidity Contentions; (2) Plaintiffs Disclosures Under Paragraph 3 of the District of Delaware Default Standard; and (3) Plaintiffs Initial Disclosures Pursuant to Rule 26(a)(1) of the Federal Rules of Civil Procedure filed by Celltech R&D Limited, UCB Pharma S.A..(Raucci, Anthony) |
| Dec 9, 2020 | N/A | Remark (0) Docket Text: The 12/10/2020 Scheduling Conference is canceled per the entry of the Scheduling Order at D.I. [18]. (nmf) |
| Dec 9, 2020 | N/A | Case Referred to Mediation (0) Docket Text: CASE REFERRED to Chief Magistrate Judge Mary Pat Thynge for Mediation. Please see Standing Order dated January 20, 2016, regarding disclosure of confidential ADR communications. A link to the standing order is provided here for your convenience at https://www.ded.uscourts.gov/sites/ded/files/forms/StandingOrderforADR-Mediation.pdf (cak) |
| Dec 9, 2020 | 18 | Scheduling Order (19) Docket Text: SCHEDULING ORDER: Case referred to the Magistrate Judge for the purpose of exploring ADR. Joinder of Parties due by 8/2/2021. Amended Pleadings due by 8/2/2021. Discovery due by 9/3/2021. Joint Claim Construction Brief due by 5/21/2021. A Markman Hearing is set for 6/17/2021 at 09:00 AM in Courtroom 4B before Judge Colm F. Connolly. Proposed Pretrial Order due by 5/12/2022. A Final Pretrial Conference is set for 6/2/2022 at 03:00 PM in Courtroom 4B before Judge Colm F. Connolly. A Jury Trial is set for 6/13/2022 at 08:30 AM in Courtroom 4B before Judge Colm F. Connolly. Signed by Judge Colm F. Connolly on 12/9/2020. (nmf) |
| Dec 9, 2020 | N/A | Oral Order (0) Docket Text: ORAL ORDER: This matter has been referred to Chief Magistrate Judge Mary Pat Thynge for ADR. Counsel are to advise on or before 1/8/21 by a JOINT EMAIL to Judge Thynge, with a copy to her Judicial Administrator, Ms. Kennedy, their clients interest in mediation and the timing when mediation is preferred with a very brief explanation why. When referencing the timing for mediation, counsel rely on certain events in the scheduling order, for example, before claim construction briefing, after the close of discovery, before expert reports and the like, they are to include the date(s) on when such event(s) occur. Ordered by Chief Magistrate Judge Mary Pat Thynge on 12/9/20. (cak) |
| Dec 8, 2020 | 17 | Proposed Order (Main Document) (19) Docket Text: PROPOSED ORDER [Proposed] Scheduling Order by Celltech R&D Limited, UCB Pharma S.A.. (Attachments: # (1) cover letter to Judge Connolly)(Raucci, Anthony) |
| Dec 8, 2020 | 17 | Proposed Order (cover letter to Judge Connolly) (1) Docket Text: PROPOSED ORDER [Proposed] Scheduling Order by Celltech R&D Limited, UCB Pharma S.A.. (Attachments: # (1) cover letter to Judge Connolly)(Raucci, Anthony) |
| Nov 19, 2020 | 16 | Order Setting Scheduling Conference (1) Docket Text: Order Setting Telephonic Scheduling Conference: A Scheduling Conference is set for 12/10/2020 at 11:00 AM before Judge Colm F. Connolly. Counsel for Plaintiffs shall coordinate the call and email the dial-in information to chambers at cfc_civil@ded.uscourts.gov. If the parties have no disputes about the scheduling order, the Court will not require the parties to appear at a conference. Signed by Judge Colm F. Connolly on 11/19/2020. (nmf) |
| Nov 3, 2020 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney Daryl L. Wiesen,Elaine H. Blais,Tiffany Mahmood,Nicholas K. Mitrokostas,James Breen for Nektar Therapeutics added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (mal) |
| Oct 22, 2020 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [15] MOTION for Pro Hac Vice Appearance of Attorney Elaine Hermann Blais, Nicholas K. Mitrokostas, Daryl Wiesen, Tiffany Mahmood and James Breen filed by Nektar Therapeutics. Signed by Judge Colm F. Connolly on 10/22/2020. (fms) |
| Oct 22, 2020 | 15 | Motion for Leave to Appear Pro Hac Vice (7) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Elaine Hermann Blais, Nicholas K. Mitrokostas, Daryl Wiesen, Tiffany Mahmood and James Breen - filed by Nektar Therapeutics. (Farnan, Kelly) |
| Sep 25, 2020 | 13 | Answer to Complaint (15) Docket Text: ANSWER to [2] Complaint, with Jury Demand by Nektar Therapeutics.(Farnan, Kelly) |
| Sep 25, 2020 | 14 | Disclosure Statement (2) Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Other Affiliate PRIMECAP Management Company, Other Affiliate Invesco Advisors, Ltd., Other Affiliate Fidelity Management & Research Company LLC for Nektar Therapeutics filed by Nektar Therapeutics. (Farnan, Kelly) |
| Aug 25, 2020 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [12] STIPULATION TO EXTEND TIME to Answer Complaint to through and including September 25, 2020 filed by Nektar Therapeutics. Set/Reset Answer Deadlines: Nektar Therapeutics answer due 9/25/2020. Signed by Judge Colm F. Connolly on 8/25/2020. (fms) |
| Aug 25, 2020 | 12 | Stipulation to EXTEND Time (2) Docket Text: STIPULATION TO EXTEND TIME to Answer Complaint to through and including September 25, 2020 - filed by Nektar Therapeutics. (Farnan, Kelly) |
| Jul 22, 2020 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [11] STIPULATION TO EXTEND TIME to move, answer or otherwise respond to the Complaint to August 26, 2020 filed by Nektar Therapeutics, Set/Reset Answer Deadlines: Nektar Therapeutics answer due 8/26/2020. Signed by Judge Colm F. Connolly on 7/22/2020. (nmf) |
| Jul 22, 2020 | 11 | Stipulation to EXTEND Time (2) Docket Text: STIPULATION TO EXTEND TIME to move, answer or otherwise respond to the Complaint to August 26, 2020 - filed by Nektar Therapeutics. (Farnan, Kelly) |
| Jun 24, 2020 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [10] STIPULATION TO EXTEND TIME re: Defendant's Answer to Complaint to through and including July 27, 2020 filed by Nektar Therapeutics. Set/Reset Answer Deadlines: Nektar Therapeutics answer due 7/27/2020. Signed by Judge Colm F. Connolly on 6/24/2020. (fms) |
| Jun 24, 2020 | 10 | Stipulation to EXTEND Time (1) Docket Text: STIPULATION TO EXTEND TIME re: Defendant's Answer to Complaint to through and including July 27, 2020 - filed by Nektar Therapeutics. (Farnan, Kelly) |
| Jun 5, 2020 | 9 | Summons Returned Executed (2) Docket Text: SUMMONS Returned Executed by UCB Pharma S.A., Celltech R&D Limited. Nektar Therapeutics served on 6/5/2020, answer due 6/26/2020. (Raucci, Anthony) |
| May 22, 2020 | 8 | Redacted Document (Main Document) (13) Docket Text: REDACTED VERSION of [2] Complaint, by Celltech R&D Limited, UCB Pharma S.A.. (Attachments: # (1) Exhibits A-H)(Raucci, Anthony) |
| May 22, 2020 | 8 | Redacted Document (Exhibits A-H) (30) Docket Text: REDACTED VERSION of [2] Complaint, by Celltech R&D Limited, UCB Pharma S.A.. (Attachments: # (1) Exhibits A-H)(Raucci, Anthony) |
| May 21, 2020 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [7] MOTION for Pro Hac Vice Appearance of Attorney James Trainor, Robert Counihan, Eric Majchrzak, Kathryn Easterling, and Eric Menist filed by UCB Pharma S.A., Celltech R&D Limited. Signed by Judge Colm F. Connolly on 5/21/2020. (fms) |
| May 20, 2020 | N/A | Case Assigned/Reassigned (0) Docket Text: Case Assigned to Judge Colm F. Connolly. Please include the initials of the Judge (CFC) after the case number on all documents filed. (rjb) |
| May 20, 2020 | 7 | Motion for Leave to Appear Pro Hac Vice (7) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney James Trainor, Robert Counihan, Eric Majchrzak, Kathryn Easterling, and Eric Menist - filed by Celltech R&D Limited, UCB Pharma S.A.. (Raucci, Anthony) |
| May 15, 2020 | N/A | Remark (0) Docket Text: Remark: Exit electronic copies to Duty Judge (CFC). (myr) |
| May 15, 2020 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [1] MOTION to Seal Complaint and Exhibits: filed by UCB Pharma S.A., Celltech R&D Limited. Signed by Judge Colm F. Connolly on 5/15/20. (rwc) |
| May 15, 2020 | N/A | Remark (0) Docket Text: Remark : Case submitted for routine judicial assignment. (rwc) |
| May 15, 2020 | 1 | Motion to Seal Document (Main Document) (3) Docket Text: PLAINTIFFS' MOTION FOR LEAVE TO FILE COMPLAINT UNDER SEAL - filed by Celltech R&D Limited, UCB Pharma S.A.. (Attachments: # (1) Text of Proposed Order)(myr) |
| May 15, 2020 | 1 | Motion to Seal Document (Text of Proposed Order) (1) Docket Text: PLAINTIFFS' MOTION FOR LEAVE TO FILE COMPLAINT UNDER SEAL - filed by Celltech R&D Limited, UCB Pharma S.A.. (Attachments: # (1) Text of Proposed Order)(myr) |
| May 15, 2020 | 3 | Magistrate Consent Forms (3) Docket Text: Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (myr) |
| May 15, 2020 | 4 | Patent/Trademark Report to Commissioner (1) Docket Text: Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 7,767,784 B2 ;8,193,306 B2 ;8,461,295 B2 ;8,809,489 B2. (myr) |
| May 15, 2020 | 5 | Disclosure Statement (1) Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent UCB S.A. and Celltech Group Limited for Celltech R&D Limited, and identifying Corporate Parent UCB S.A. for UCB Pharma S.A. filed by Celltech R&D Limited, UCB Pharma S.A.(myr). |
| May 15, 2020 | 6 | Summons Issued - Electronic (2) Docket Text: Summonses Issued (please complete the top portion of the form and print out for use/service). (myr) |
